18 February 2022>: Original Paper
Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network/United Network for Organ Sharing Policy in the United StatesShingo Shimada 1ADEF , Toshihiro Kitajima 1BCE , Yukiko Suzuki 1BD , Yasutaka Kuno 1BD , Tayseer Shamaa 1BC , Tommy Ivanics 1BCE , Kelly Collins 1DE , Michael Rizzari 1BD , Atsushi Yoshida 1BD , Marwan Abouljoud 1BD , Dilip Moonka 2BD , Shunji Nagai 1ACE*
Ann Transplant 2022; 27:e934850
Table 2 The 90-day waitlist mortality risk and transplant probability after the 2017 policy (ref. before the 2017 policy).
|90-day waitlist mortality||90-day transplant probability|
|aHR*||95% CI||P value||aHR*||95% CI||P value|
|35 or higher||0.83||0.54–1.27||0.40||1.24||1.02–1.51||0.03|
|29 or lower||0.72||0.52–0.99||0.04||0.97||0.82–1.14||0.74|
|* Hazards were adjusted by Fine-Gray model for recipient age, sex, race, Karnofsky score MELD score, at registration, presence of ascites, hepatic encephalopathy, dialysis requirement at registration and United Network for Organ Sharing (UNOS) region (1–11).|
aHR – adjusted hazard ratio; CI – confidence interval; MELD – model for end-stage liver disease.